Abbott - About the company
Abbott is a public company based in Libertyville (United States), founded in 1888 by Wallace Calvin Abbott and Wallace Calvin Abbott. It operates as a Developer of medical devices, generic pharmaceuticals, and nutrition products. Abbott has raised an undisclosed amount in funding.
Company Details
Developer of medical devices, generic pharmaceuticals, and nutrition products. Its products are used by hospitals, laboratories, blood banks, and physicians. It is used to diagnose & monitor diseases such as HIV, hepatitis, cancer, heart failure, and metabolic disorders. In 2022, the company recorded annual revenues of $43.65B and a net profit of $6.93B
- Email ID
- *****@abbott.com
- Phone Number
- +1 **********
- Registered Address
- Phoenix, Arizona
Key Metrics
Founded Year
1888
Location
Libertyville, United States
Stage
Public
Latest Funding Round
Investors
Annual Revenue
$1B+ as on Dec 31, 2025
Employee Count
144,111 as on Apr 30, 2026
Investment & Acquisitions
Similar Companies
Exit Details
Public
Legal entities associated with Abbott
Abbott is associated with 15 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
ABBOTT COMPANY, LTD. CIN: 860485253 , United States, Active | Dec 26, 999 | - | 7 (As on Dec 31, 2024) | - |
ABBOTT DIAGNOSTICS MEDICAL PRIVATE LIMITED CIN: U74899DL1995PTC069456 , India, Active | Jun 06, 1995 | ₹100 - ₹500 Cr (As on Mar 31, 2025) | 57 (As on Apr 01, 2026) | |
ABBOTT PAEDIATRIC MENTAL HEALTH LTD. CIN: 10180117 , United Kingdom, Active | May 12, 2016 | £0 - £1M (As on May 31, 2025) | 2 (As on May 31, 2024) | |
ABBOTT GROUP INC. CIN: 263489598 , United States, Active | Dec 31, 1999 | - | 2 (As on Dec 31, 2018) | - |
ABBOTT & ABBOTT LIMITED CIN: 9150841 , United Kingdom, Active | Jul 28, 2014 | - | 5 (As on Mar 31, 2025) | |
ABBOTT HEALTHCARE (PUERTO RICO) LTD. C/O ABBOTT LABORATORIES CIN: 981051267 , United States, Active | - | 1618 (As on Dec 31, 2024) | - | |
ABBOTT LABORATORIES COMPANY LIMITED CIN: 0105509002106 , Thailand, Active | Jun 27, 1966 | $100M - $500M (As on Dec 31, 2022) | - | |
ABBOTT CORPORATION CIN: 940266235 , United States, Active | Dec 31, 1999 | $1B+ (As on Dec 31, 2023) | 4 (As on Dec 31, 2024) | - |
ABBOTT DIAGNOSTICS TECHNOLOGIES AS CIN: 981363019 , Norway, Active | Dec 05, 1999 | - | 311 (As on Dec 31, 2022) | |
Abbott Laboratories Baltics CIN: 50003693601 , Latvia, Active | Aug 09, 2004 | €1M - €10M (As on Dec 31, 2024) | 9 (As on Dec 31, 2022) | - |
ABBOTT LABORATORIES D.O.O. CIN: 90392016912 , Croatia, Active | Aug 25, 2004 | $10M - $50M (As on Dec 31, 2018) | - | |
Abbott Laboratories CIN: 360698440 , United States, Active | $1B+ (As on Dec 31, 2025) | 38001 (As on Dec 31, 2024) | - | |
ABBOTT HEALTHCARE PRIVATE LIMITED CIN: U24200MH1997PTC104834 , India, Active | Jan 01, 1997 | ₹1,000+ Cr (As on Mar 31, 2025) | 7455 (As on Feb 01, 2026) | |
ABBOTT INDUSTRIES, INC. CIN: 730973011 , United States, Active | Dec 31, 1999 | - | 108 (As on Dec 31, 2022) | - |
ABBOTT INDIA LIMITED CIN: L24239MH1944PLC007330 , India, Active | Aug 22, 1944 | ₹1,000+ Cr (As on Mar 31, 2025) | 3651 (As on Apr 01, 2026) |
Abbott's IPO details
Abbott got listed on Jan 06, 1978.
Click here to take a look at Abbott's IPO in detail
Sign up to download Abbott's company profile
Abbott's funding and investors
Abbott has raised funding over 21 rounds. Its first funding round was on Apr 01, 2015. Its latest funding round was a Grant (prize money) round on Nov 17, 2021 for $*****. 1 investor participated in its latest round. Abbott has 14 institutional investors.
Here is the list of recent funding rounds of Abbott:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 17, 2021 | 6335028 | Grant (prize money) | 4792100 | 8586367 | 2854829 | 3777628 |
Nov 02, 2021 | 4774275 | Grant (prize money) | 4878130 | 6731270 | 9559032 | |
Oct 06, 2021 | 8207816 | Grant (prize money) | 7458826 | 3243513 | 9541089 |
View details of Abbott's funding rounds and investors
Abbott's founders and board of directors
Founder? Claim ProfileThe founders of Abbott are Wallace Calvin Abbott and Wallace Calvin Abbott. Robert B Ford and Robert Ford are the CEOs of Abbott.
Here are the details of Abbott's key team members:
- Wallace Calvin Abbott: Former Founder of Abbott and founder of 3 other companies, Laboratorio Internacional Argentino, Abbott Diagnostics and Abbott Laboratories.
- Wallace Calvin Abbott: Former Founder of Abbott and founder of 1 other company.
- Robert B Ford: CEO of Abbott. They serve on the board of 1 company.
- Robert Ford: CEO of Abbott. Contact Info: 1 email address
View details of Abbott's Founder profiles and Board Members
Abbott's employee count trend
Abbott has 144,111 employees as of Apr 26. Here is Abbott's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Abbott's Investments and acquisitions
Abbott has made 13 investments in companies including NVision Quantum and Whoop. Abbott has also acquired 30 companies including Exact Sciences and LARALAB.Here is the list of investments & acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
May 13, 2026 | Investments | 2016 | ||
Mar 31, 2026 | Investments | 2012 | Boston (United States) | |
Mar 20, 2026 | Acquisition | 1995 | Madison (United States) |
See all investments and acquisitions by Abbott
Reports related to Abbott
Here is the latest report on Abbott's sector:
News related to Abbott
Media has covered Abbott for a total of 183 events in the last 1 year, 129 of them have been about company updates and 8 about partnerships.
•
•
Abbott Laboratories Defeats Shareholder Lawsuit Over 2022 Infant Formula RecallInsurance Journal•Jul 27, 2026•Abbott
•
Wisner Baum Lawsuits Challenge FDA Oversight of Spinal Cord ImplantsPR Newswire•Jul 22, 2026•Boston Scientific, Medtronic, Abbott, Nevro and 1 other
•
Abbott to launch Libre Duo dual sensor internationally in the fall, expects future reimbursement catalystsDrug Delivery Business•Jul 17, 2026•Abbott
•
•
Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS GuidancePR Newswire•Jul 16, 2026•Abbott
•
Abbott's Longer Length Esprit BTK Drug-Eluting Scaffold Gets FDA OKMedical Product Outsourcing•Jul 13, 2026•Abbott
•
Abbott Expands Rashfree™ Portfolio with New Eva Cream and Spray for Women and Elderly AdultsIndiaMedToday•Jul 02, 2026•Abbott
•
Abbott (ABT) director Kevin Conroy receives 231 stock equivalent units as feesStocktitan•Jul 01, 2026•Abbott
•
Are you a Founder ?
FAQs about Abbott
Explore our recently published companies
- Phoenix - Kolkata based, Unfunded company
- Miscellaneous Staffing - Kansas City based, 2020 founded, Unfunded company
- Malaysia Milk - Petaling Jaya based, Unfunded company
- Shaanxi Dideu Medichem - Austin based, Unfunded company
- Yrgo - Sweden based, Unfunded company
- Capvest Advisors - Switzerland based, Unfunded company